jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

May. 29, 2014

Dec. 17, 2018

jRCT2080222503

Clinical trial of KIB-PCI in healthy Japanese children

version:
date:

DAIICHI SANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html

150

Interventional

A multicenter, uncontrolled, open-label study

2-3

Healthy Japanese children

1) Subjects with history of H5N1 influenza
2) Subjects with history of H5N1 influenza vaccination

No limit
19age old under

Both

Prophylaxis of new type of influenza infection

investigational material(s)
Generic name etc : KIB-PCI (H5N1 influenza vaccin)
INN of investigational material :
Therapeutic category code : 631 Vaccines
Dosage and Administration for Investigational material : Intramuscular

SRH antibody titer

Neutralizing antibody titer

DAIICHISANKYO Co.,Ltd.
KITASATO DAIICHI SANKYO VACCINE COMPANY, LIMITED

JapicCTI-142554

History of Changes

No Publication date
11 Dec. 17, 2018 (this page) Changes
10 Nov. 01, 2016 Detail Changes
9 Nov. 01, 2016 Detail Changes
8 Feb. 20, 2015 Detail Changes
7 Feb. 20, 2015 Detail Changes
6 Oct. 03, 2014 Detail Changes
5 Oct. 03, 2014 Detail Changes
4 June. 24, 2014 Detail Changes
3 June. 24, 2014 Detail Changes
2 May. 29, 2014 Detail Changes
1 May. 29, 2014 Detail